Active Cancer or “History Of”: When a C Code Becomes Z85

Section I.C.2 states both halves of the boundary:

“When a primary malignancy has been excised but further treatment, such as an additional surgery for the malignancy, radiation therapy or chemotherapy is directed to that site, the primary malignancy code should be used until treatment is completed.”

“When a primary malignancy has been previously excised or eradicated from its site, there is no further treatment (of the malignancy) directed to that site, and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy.”

Read as a test, Z85 requires all three: excised or eradicated, no further treatment directed to the site, and no evidence of disease at the site. Fail any one and the C code is still the correct code — most importantly during adjuvant chemotherapy or radiation after a “successful” surgery, the phase where the wrong switch to Z85 most often happens.

The surgery-plus-adjuvant episode has its own sequencing sentence: when an encounter is for the surgical removal of a neoplasm followed by adjunct chemotherapy or radiation during the same episode, the neoplasm code is the principal or first-listed diagnosis. And when an encounter is chiefly for administering the therapy, Z51.11 (chemotherapy), Z51.12 (immunotherapy) or Z51.0 (radiation) is first-listed, with the malignancy coded after it.

The Z08 pairing is stated by both codes: category Z85 carries “Code first any follow-up examination after treatment of malignant neoplasm (Z08),” and Z08 reciprocates with Use Additional Code notes for the Z85.- history and any Z90.- acquired absence of organ — the same interlocking-notes pattern the classification uses wherever a code pair is meant to travel together.

Secondary sites have their own boundary. The Guidelines restrict subcategories Z85.0–Z85.85 to former sites of primary malignancy; a former secondary (metastatic) site takes Z85.89, which covers former sites of either kind.

Z85 is never the principal diagnosis on a Medicare inpatient claim. Sixty Z85 codes sit on the MCE unacceptable-principal-diagnosis list (v43.1, edit 09) — the machine-enforced version of what the classification already implies: a history code describes context, not the reason for admission. The full status-code logic is in when can a Z code be the primary diagnosis?

Recurrence at the site ends the history. “No evidence of any existing primary malignancy at that site” is part of the test — documented recurrence returns the coding to the C code, and the Z85 code does not appear alongside it for the same site.

This is a consequence, not a coding rule, and it is worth naming because it is why the active-vs-history call gets audited from both directions. An active breast malignancy such as C50.911 maps to CMS-HCC V28 category 23 (Prostate, Breast, and Other Cancers and Tumors); Z85.3, the history code for the same anatomy, maps to nothing. Coding history as active overstates risk; coding active disease as history understates it. Neither direction changes the rule above — the three-part test decides the code, and the payment consequence follows the code, never the other way around.

1. Ask whether any treatment is still directed at the malignancy at that site, or whether there is any evidence of disease there.
2. Yes to either → the C code (active), sequenced by the reason for the encounter; Z51.1- first when the visit is for therapy administration.
3. No to all three parts of the test (excised or eradicated; no further treatment to the site; no evidence of disease) → Z85.- as a secondary code.
4. Surveillance visit → Z08 first, then Z85.-.
5. Recurrence at the site → back to the C code; Z85 not reported for that site.

1. Adjuvant chemotherapy after lumpectomy. Z51.11, then C50.911 — still active.
2. Surveillance two years after completed treatment, no evidence of disease. Z08, then Z85.3.
3. Former metastatic site, treatment complete. Z85.89 — Z85.0–Z85.85 are for former primary sites.

• Z85 during adjuvant therapy.
• Z85 as principal diagnosis.
• Z85.3 for a former secondary site — Z85.89.
• C code and Z85 for the same site on the same claim.

• Whether treatment is still directed at the site, and its completion.
• Evidence of disease at the site, or recurrence.
• Whether the former site was a primary or a secondary malignancy.